Analyze Diet
Blut1989; 58(3); 129-132; doi: 10.1007/BF00320431

Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda) in two horses.

Abstract: Tumorous amyloid deposits in the nasal mucosa of two horses differed from generalized AA-amyloidosis with respect to clinical features, organ distribution, and resistance to KMnO4 treatment. Using a panel of antibodies directed against different human amyloid fibril proteins and employing the peroxidase-anti-peroxidase (PAP) technique, we showed the described equine amyloid to be A lambda-type, as demonstrated by immunohistochemical cross-reactivity. Consequently, we identified a second amyloid class in horses and showed that immunoglobulin light-chain-derived amyloid may also be present in animals.
Publication Date: 1989-03-01 PubMed ID: 2495038DOI: 10.1007/BF00320431Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article describes a study where a type of amyloidosis – Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda) – was identified in two horses. This type of amyloidosis, previously unknown in animals, was found to have unique characteristics compared to the commonly-found AA-amyloidosis, shedding light on a new class of this disease in the animal kingdom.

Study Background

  • The study investigated unusual tumorous amyloid deposits found in the nasal mucosa of two horses. These were markedly different from the general AA-amyloidosis found commonly in horses.
  • This posed an interesting proposition, leading the researchers to investigate if this was a different type of amyloidosis altogether.

Methodology

  • To confirm this, the researchers used antibodies directed against different human amyloid fibril proteins as the enforced peroxidase-anti-peroxidase (PAP) technique, a common practice in histology to identify specific antigens.
  • Further, they studied the resistance of these deposits to KMnO4 treatment – a characteristic feature of some types of amyloidosis.
  • These procedures would help determine if these deposits represented a different type of amyloidosis and if there was a cross-reactivity to the antibodies.

Findings

  • Upon performing these tests, the researchers found that the amyloid deposits were indeed different from typical AA-amyloidosis. The deposits displayed cross-reactivity to the antibodies used, signifying that they were of a different origin.
  • These were confirmed to be Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda), a type of amyloidosis hitherto known only in humans.

Implications

  • The discovery of this form of amyloidosis in horses broadens the understanding of this disease in animals. This is significant as this could affect diagnostic and therapeutic strategies in veterinary medicine.
  • Notably, this research identifies a second class of amyloidosis in horses, expanding the known range of this disease in the animal kingdom.

Cite This Article

APA
Linke RP, Trautwein G. (1989). Immunoglobulin lambda-light-chain-derived amyloidosis (A lambda) in two horses. Blut, 58(3), 129-132. https://doi.org/10.1007/BF00320431

Publication

ISSN: 0006-5242
NlmUniqueID: 0173401
Country: Germany
Language: English
Volume: 58
Issue: 3
Pages: 129-132

Researcher Affiliations

Linke, R P
  • Institut für Immunologie, Universität München, Federal Republic of Germany.
Trautwein, G

    MeSH Terms

    • Amyloid / analysis
    • Amyloid / immunology
    • Amyloidosis / complications
    • Amyloidosis / immunology
    • Animals
    • Cross Reactions
    • Female
    • Horse Diseases / immunology
    • Horse Diseases / metabolism
    • Horse Diseases / pathology
    • Horses
    • Humans
    • Immunoglobulin lambda-Chains / analysis
    • Immunohistochemistry
    • Male
    • Nasal Mucosa / analysis
    • Nasal Mucosa / pathology
    • Nose Neoplasms / analysis
    • Nose Neoplasms / complications
    • Nose Neoplasms / veterinary

    References

    This article includes 21 references
    1. Chai CK, Lerner C. Amyloidosis development in LLC mice.. Exp Cell Biol 1984;52(6):339-46.
      pubmed: 6500158doi: 10.1159/000163280google scholar: lookup
    2. Linke RP. Monoclonal antibodies against amyloid fibril protein AA. Production, specificity, and use for immunohistochemical localization and classification of AA-type amyloidosis.. J Histochem Cytochem 1984 Mar;32(3):322-8.
      pubmed: 6363521doi: 10.1177/32.3.6363521google scholar: lookup
    3. Yonezu T, Higuchi K, Tsunasawa S, Takagi S, Sakiyama F, Takeda T. High homology is present in the primary structures between murine senile amyloid protein (ASSAM) and human apolipoprotein A-II.. FEBS Lett 1986 Jul 28;203(2):149-52.
      pubmed: 3089836doi: 10.1016/0014-5793(86)80732-3google scholar: lookup
    4. Linke RP, Sipe JD, Pollock PS, Ignaczak TF, Glenner GG. Isolation of a low-molecular-weight serum component antigenically related to an amyloid fibril protein of unknown origin.. Proc Natl Acad Sci U S A 1975 Apr;72(4):1473-6.
      pubmed: 805429doi: 10.1073/pnas.72.4.1473google scholar: lookup
    5. MCALPINE JC, FULLER AP. LOCALIZED LARYNGEAL AMYLOIDOSIS, A REPORT OF A CASE WITH A REVIEW OF THE LITERATURE.. J Laryngol Otol 1964 Mar;78:296-314.
      pubmed: 14128068doi: 10.1017/s0022215100062113google scholar: lookup
    6. Wright JR, Calkins E, Humphrey RL. Potassium permanganate reaction in amyloidosis. A histologic method to assist in differentiating forms of this disease.. Lab Invest 1977 Mar;36(3):274-81.
      pubmed: 839739
    7. Glenner GG, Eanes ED, Bladen HA, Linke RP, Termine JD. Beta-pleated sheet fibrils. A comparison of native amyloid with synthetic protein fibrils.. J Histochem Cytochem 1974 Dec;22(12):1141-58.
      pubmed: 4443557doi: 10.1177/22.12.1141google scholar: lookup
    8. Zschiesche W, Linke RP. Immunohistochemical characterization of spontaneous amyloidosis in captive birds as AA-type, using monoclonal and polyclonal anti-AA antibodies against mammalian amyloid.. Acta Histochem 1989;86(1):45-50.
      pubmed: 2505480doi: 10.1016/S0065-1281(89)80046-7google scholar: lookup
    9. van de Kaa CA, Hol PR, Huber J, Linke RP, Kooiker CJ, Gruys E. Diagnosis of the type of amyloid in paraffin wax embedded tissue sections using antisera against human and animal amyloid proteins.. Virchows Arch A Pathol Anat Histopathol 1986;408(6):649-64.
      pubmed: 3085332doi: 10.1007/BF00705343google scholar: lookup
    10. Linke RP. Immunochemical typing of amyloid deposits after microextraction from biopsies.. Appl Pathol 1985;3(1-2):18-28.
      pubmed: 3939489
    11. Husebekk A, Husby G, Sletten K, Marhaug G, Nordstoga K. Characterization of amyloid protein AA and its serum precursor SAA in the horse.. Scand J Immunol 1986 Jun;23(6):703-9.
    12. Scheinberg MA, Cathcart ES, Eastcott JW, Skinner M, Benson M, Shirahama T. The SJL/J mouse: a new model for spontaneous age-associated amyloidosis. I. Morphologic and immunochemical aspects.. Lab Invest 1976 Jul;35(1):47-54.
      pubmed: 781403
    13. Westermark P, Wernstedt C, O'Brien TD, Hayden DW, Johnson KH. Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone.. Am J Pathol 1987 Jun;127(3):414-7.
      pubmed: 3296768
    14. Geisel O, Linke RP. Generalized AA-amyloidosis in two hares (Lepus europaeus) immunohistochemically identified using poly- and monoclonal antibodies.. Vet Pathol 1988 Sep;25(5):391-3.
      pubmed: 3068895doi: 10.1177/030098588802500511google scholar: lookup
    15. Linke RP. Immunohistochemical identification and cross reactions of amyloid fibril proteins in senile heart and amyloid in familial polyneuropathy. Lack of reactivity with cerebral amyloid in Alzheimer's disease.. Clin Neuropathol 1982;1(4):172-82.
      pubmed: 6301727
    16. Westermark P, Sletten K, Pitkänen P, Natvig JB, Lindholm CE. Localized laryngeal amyloidosis: partial characterization of an amyloid fibril protein AL.. Mol Immunol 1982 Mar;19(3):447-50.
      pubmed: 6808355doi: 10.1016/0161-5890(82)90210-3google scholar: lookup
    17. Stünzi H, Ehrensperger F, Wild P, Leemann W. [Systemic cutaneous and subcutaneous amyloidosis in the horse].. Vet Pathol 1975;12(5-6):405-14.
      pubmed: 1229055doi: 10.1177/0300985875012005-00607google scholar: lookup
    18. Dill GS Jr, Stookey JL, Whitney GD. Nodular amyloidosis in the trachea of a dog.. Vet Pathol 1972;9(4):238-42.
      pubmed: 4671497doi: 10.1177/030098587200900402google scholar: lookup
    19. Jakob W. Spontaneous amyloidosis of mammals.. Vet Pathol 1971;8(4):292-306.
      pubmed: 4950728doi: 10.1177/030098587100800402google scholar: lookup
    20. Linke RP, Hol PR, Geisel O. Immunohistochemical identification of generalized AA-amyloidosis in a mountain gazelle (Gazella gazella).. Vet Pathol 1986 Jan;23(1):63-7.
      pubmed: 3511600doi: 10.1177/030098588602300110google scholar: lookup
    21. Linke RP, Hol PR, Gruys E, Geisel O, Nathrath WB, Trautwein G. Immunohistochemical identification and crossreactions of amyloid-A fibril protein in man and eleven other species.. J Comp Pathol 1984 Jul;94(3):339-56.
      pubmed: 6432863doi: 10.1016/0021-9975(84)90022-7google scholar: lookup

    Citations

    This article has been cited 1 times.
    1. Østevik L, Gunnes G, de Souza GA, Wien TN, Sørby R. Nasal and ocular amyloidosis in a 15-year-old horse.. Acta Vet Scand 2014 Aug 27;56(1):50.
      doi: 10.1186/s13028-014-0050-6pubmed: 25159190google scholar: lookup